Clinical Outcomes and Risks in Post-Ibrutinib Transplant
In an era marked by rapid advancements in targeted therapies for hematologic malignancies, the management of relapsed or refractory mantle ...
In an era marked by rapid advancements in targeted therapies for hematologic malignancies, the management of relapsed or refractory mantle ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine